Literature DB >> 1992392

EDSS reliability.

D E Goodkin.   

Abstract

Mesh：

Year:  1991        PMID： 1992392     DOI： 10.1212/wnl.41.2_part_1.332

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  12 in total

Review 1.  First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.

Authors:  Jessica Johnston; Tsz-Yin So
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

2.  Walking function in clinical monitoring of multiple sclerosis by telemedicine.

Authors:  Núria Sola-Valls; Yolanda Blanco; Maria Sepúlveda; Sara Llufriu; Elena H Martínez-Lapiscina; Delon La Puma; Francesc Graus; Pablo Villoslada; Albert Saiz
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

3.  Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis.

Authors:  J L Neva; B Lakhani; K E Brown; K P Wadden; C S Mang; N H M Ledwell; M R Borich; I M Vavasour; C Laule; A L Traboulsee; A L MacKay; L A Boyd
Journal:  Behav Brain Res       Date:  2015-10-20       Impact factor: 3.332

4.  Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Richard K Burt; Roumen Balabanov; Joachim Burman; Basil Sharrack; John A Snowden; Maria Carolina Oliveira; Jan Fagius; John Rose; Flavia Nelson; Amilton Antunes Barreira; Kristina Carlson; Xiaoqiang Han; Daniela Moraes; Amy Morgan; Kathleen Quigley; Kimberly Yaung; Regan Buckley; Carri Alldredge; Allison Clendenan; Michelle A Calvario; Jacquelyn Henry; Borko Jovanovic; Irene B Helenowski
Journal:  JAMA       Date:  2019-01-15       Impact factor: 56.272

5.  One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.

Authors:  E L J Hoogervorst; M J Eikelenboom; B M J Uitdehaag; C H Polman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

6.  Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.

Authors:  Mohamed Boucekine; Anderson Loundou; Karine Baumstarck; Patricia Minaya-Flores; Jean Pelletier; Badih Ghattas; Pascal Auquier
Journal:  BMC Med Res Methodol       Date:  2013-02-15       Impact factor: 4.615

7.  Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.

Authors:  Gabriel Bsteh; Rainer Ehling; Andreas Lutterotti; Harald Hegen; Franziska Di Pauli; Michael Auer; Florian Deisenhammer; Markus Reindl; Thomas Berger
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

8.  Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.

Authors:  Gabriel Bsteh; Rainer Ehling; Lisa-Maria Walchhofer; Harald Hegen; Michael Auer; Sebastian Wurth; Franziska Di Pauli; Michaela Wagner; Markus Reindl; Florian Deisenhammer; Thomas Berger
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

9.  Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.

Authors:  Su Hyun Kim; Ho Jin Kim; Woojun Kim; Eun Young Park; Jae Won Hyun; So Young Huh; Na Young Park; Hyunmin Jang
Journal:  J Clin Neurol       Date:  2020-04       Impact factor: 3.077

10.  Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.

Authors:  Janina Behrens; Caspar Pfüller; Sebastian Mansow-Model; Karen Otte; Friedemann Paul; Alexander U Brandt
Journal:  J Neuroeng Rehabil       Date:  2014-05-27       Impact factor: 4.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.